Patients
Part of PRE-ACT Horizons project is the communication with public, patients and fomer patients. The participation with (former) patients is important for PRE-ACT. That is why we present the information on this part of the website. We see patients as experts by experience. And that is why they can give us valuable input. Suggestions and/or comments are welcome on this email address: info@preact-horizoneurope.eu.
PRE-ACT plans to use Artificial Intelligence* to predict the risk of side effects, such as arm lymphedema, from radiotherapy, specifically for breast cancer patients. An app will be developed that helps both doctors and patients to make informed decisions about possible treatment. Important is the upcoming so called 'clinical trial' in which patients can participate. Read more about it on this page.
* Artificial intelligence (AI) is an umbrella term for computer programmes that do things we thought only humans could do. AI systems demonstrate smart behaviour by looking beyond problems or tasks and taking independent action to achieve a goal. It is not just about fast calculations, but mainly about the ability to learn and make decisions. This learning ability is typical of artificial intelligence. AI uses rules created by humans or that the programme itself creates using data. AI trains itself with numerous data sources to get better and better.
Horizon Europe/Grants
This work is conducted as part of of the Horizon Europe project PRE-ACT (Prediction of Radiotherapy side effects using explainable AI for patient communication and treatment modification). Ιt is supported by the European Commission through the Horizon Europe Program (Grant Agreement number 101057746), by the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number 22 00058, and by the UK government (Innovate UK application number 10061955)
Partners
